The Midwest Reproductive Symposium and SRxA Enter Into an Exclusive

Publications Collaboration

Washington, DC, March 25, 2011 --(PR.com)-- SRxA Strategic Pharmaceutical Advisors, a leading
healthcare consulting, marketing and education firm, is pleased to announce that it has entered into an
agreement with the Executive Directors and organizers of the Midwest Reproductive Symposium (MRS)
and Fertility Centers of Illinois (FCI), to become the exclusive provider of rapid dissemination
post-congress e-newsletters.

The MRS is an annual educational program started in 2005 to promote the timely discussion of issues
relevant to reproductive medicine. Today, the MRS is internationally recognized as a program of
excellence, providing the most up-to-date information on clinical and research topics of current interest,
and sometimes, controversial. The MRS offers attendees a unique opportunity to network with faculty
and colleagues in casual and formal educational venues. Sessions and workshops during the 2-day
program are designed for maximal interaction; a REI Fellows Poster Session is included; and a Nurse
Practicum Day - developed by nurses for nurses - precedes the meeting.

The 2011 MRS is scheduled for June 9-11 at the Drake Hotel, Chicago. Attendance is limited to 250.
However, in recent years, more than 250 physicians, nurses, embryologists, psychologists, and other
health care professionals have expressed interest in the program. In response, the Executive Committee is
pursuing several options for disseminating information from and about the meeting,

To this end, SRxA and its team of Reproductive Health Advisors will develop, produce and distribute an
interactive e-newsletter within four weeks of the Symposium. The e-newsletter will feature a blend of
scientific session reviews, “hot topic” discussions, key takeaway messages, news from the exhibit hall,
and other pertinent information. This will be distributed electronically to more than 10,000 US-based
health professionals and scientists in reproductive medicine.

Publication and distribution of the e-newsletter will include the support of multiple pharmaceutical and
device industry sponsors, who will be prominently acknowledged. Sponsorship efforts are ongoing.

“This electronic newsletter will enable us to reach a much wider audience than we have previously been
able to address due to the capacity of the live event. It will be a perfect complement to the program and
will provide both attendees and non-attendees with a true flavor of the MRS. SRxA was the natural
choice for a partner in this endeavor because of the depth of their knowledge and expertise in
Reproductive Health and their unique ability to produce informative and intriguing peer-reviewed, rapid
electronic publications following scientific congresses,” said Dr. Angeline Beltsos, MRS Chairperson and
FCI Medical Director.

“We are delighted to work with Dr. Beltsos and her team to develop and produce a unique vehicle that
will distribute pertinent information in a timely fashion to the medical communities they serve,”
commented Christos Efessiou, PhD, SRxA's Chief Executive Officer.

Page 1/3
PR.com Press Release Distribution Terms of Use
SRxA operates on a unique business model that utilizes independent clinical teams of national and
international Key Opinion Leaders who advise pharmaceutical and medical device clients in research,
clinical, regulatory, education and business matters. SRxA advisory groups focus in key therapeutic areas
such as Allergy, Otolaryngology, Pulmonary Diseases, Respiratory Medicine (Europe), Ophthalmology,
Health Outcomes, Reproductive Endocrinology and Genetics, Aesthetics, and Behavioral Health. The
company is headquartered in Washington, DC with offices in London and Hong Kong. For more
information, please contact Judi Miller at 202.316.8692, jmiller@SRxA.com, or visit www.srxa.com.

Fertility Centers of Illinois, S.C., (FCI), founder and host organization of the MRS, is one of the nation's
leading infertility treatment practices, providing advanced reproductive endocrinology services in the
Chicago area for more than 30 years. Offering some of the most sophisticated reproductive technology
services currently available, FCI is one of a handful of referral centers for advanced genetic and fertility
treatments. FCI is part of IntegraMed, the nation's largest and most reputable network of fertility centers.

Contact
Judi Miller
202.316.8692
jmiller@SRxA.com

###

Page 2/3
PR.com Press Release Distribution Terms of Use
Contact Information:
SRxA Strategic Pharmaceutical Advisors, LLC
Judi Miller
202.316.8692
jmiller@srxa.com
www.srxa.com

Online Version of Press Release:

You can read the online version of this press release at: http://www.pr.com/press-release/308686

Page 3/3
PR.com Press Release Distribution Terms of Use